Liver X Receptors Protect from Development of Prostatic Intra-Epithelial Neoplasia in Mice

English version České info

LXR (Liver X Receptors) act as “sensor” proteins that regulate cholesterol uptake, storage, and efflux. LXR signaling is known to influence proliferation of different cell types including human prostatic carcinoma (PCa) cell lines. This study shows that deletion of LXR in mouse fed a high-cholesterol diet recapitulates initial steps of PCa development. Elevation of circulating cholesterol in Lxrαβ-/- double knockout mice results in aberrant cholesterol ester accumulation and prostatic intra-epithelial neoplasia. This phenotype is linked to increased expression of the histone methyl transferase EZH2 (Enhancer of Zeste Homolog 2), which results in the down-regulation of the tumor suppressors Msmb and Nkx3.1 through increased methylation of lysine 27 of histone H3 (H3K27) on their promoter regions. Altogether, our data provide a novel link between LXR, cholesterol homeostasis, and epigenetic control of tumor suppressor gene expression.

Vyšlo v časopise: Liver X Receptors Protect from Development of Prostatic Intra-Epithelial Neoplasia in Mice. PLoS Genet 9(5): e32767. doi:10.1371/journal.pgen.1003483
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003483

Souhrn

Zdroje

1. TontonozP, MangelsdorfDJ (2003) Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 17: 985–993.

2. MangelsdorfDJ, EvansRM (1995) The RXR heterodimers and orphan receptors. Cell 83: 841–850.

3. ViennoisE, PommierAJ, MouzatK, OumeddourA, El HajjajiFZ, et al. (2011) Targeting liver X receptors in human health: deadlock or promising trail? Expert Opin Ther Targets 15: 219–232 doi:10.1517/14728222.2011.547853.

4. KimHJ, AnderssonLC, BoutonD, WarnerM, GustafssonJA (2009) Stromal growth and epithelial cell proliferation in ventral prostates of liver X receptor knockout mice. Proc Natl Acad Sci U S A 106: 558–563.

5. ViennoisE, EspositoT, DufourJ, PommierA, FabreS, et al. (2012) Lxrá regulates the androgen response in prostate epithelium. Endocrinology 153: 3211–3223 doi:10.1210/en.2011-1996.

6. FukuchiJ, KokontisJM, HiipakkaRA, ChuuCP, LiaoS (2004) Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res 64: 7686–7689.

7. ChuuCP, HiipakkaRA, KokontisJM, FukuchiJ, ChenRY, et al. (2006) Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. Cancer Res 66: 6482–6486.

8. PommierAJ, AlvesG, ViennoisE, BernardS, CommunalY, et al. (2010) Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene 29: 2712–2723.

9. FukuchiJ, HiipakkaRA, KokontisJM, HsuS, KoAL, et al. (2004) Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells. Cancer Res 64: 7682–7685.

10. LlaveriasG, DaniloC, WangY, WitkiewiczAK, DaumerK, et al. (2010) A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer. Am J Pathol 177: 3180–3191 doi:S0002-9440(10)62941-0[pii]10.2353/ajpath.2010.100568.

11. ZhuangL, KimJ, AdamRM, SolomonKR, FreemanMR (2005) Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest 115: 959–968.

12. JoyceCW, AmarMJA, LambertG, VaismanBL, PaigenB, et al. (2002) The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci USA 99: 407–412 doi:10.1073/pnas.012587699.

13. ParkJH, WallsJE, GalvezJJ, KimM, Abate-ShenC, et al. (2002) Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol 161: 727–735 doi:S0002-9440(10)64228-9[pii]10.1016/S0002-9440(10)64228-9.

14. ZhangK, KaufmanRJ (2003) Unfolding the toxicity of cholesterol. Nat Cell Biol 5: 769–770 doi:10.1038/ncb0903-769.

15. WangS, GaoJ, LeiQ, RozengurtN, PritchardC, et al. (2003) Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4: 209–221.

16. DingZ, WuC-J, ChuGC, XiaoY, HoD, et al. (2011) SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature 470: 269–273 doi:10.1038/nature09677.

17. ZelcerN, HongC, BoyadjianR, TontonozP (2009) LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 325: 100–104.

18. BerquinIM, MinY, WuR, WuH, ChenYQ (2005) Expression signature of the mouse prostate. J Biol Chem 280: 36442–36451.

19. FreemanMR, SolomonKR (2004) Cholesterol and prostate cancer. J Cell Biochem 91: 54–69.

20. YuYP, LandsittelD, JingL, NelsonJ, RenB, et al. (2004) Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 22: 2790–2799 doi:10.1200/JCO.2004.05.158.

21. TaylorBS, SchultzN, HieronymusH, GopalanA, XiaoY, et al. (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18: 11–22 doi:10.1016/j.ccr.2010.05.026.

22. ChenY, Hughes-FulfordM (2001) Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2. Int J Cancer 91: 41–45.

23. LeeJH, GongH, KhademS, LuY, GaoX, et al. (2008) Androgen deprivation by activating the liver X receptor. Endocrinology 149: 3778–3788.

24. VaramballyS, DhanasekaranSM, ZhouM, BarretteTR, Kumar-SinhaC, et al. (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624–629 doi:10.1038/nature01075.

25. KunderfrancoP, Mello-GrandM, CangemiR, PelliniS, MensahA, et al. (2010) ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer. PLoS ONE 5: e10547 doi:10.1371/journal.pone.0010547.

26. BekeL, NuyttenM, Van EyndeA, BeullensM, BollenM (2007) The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2. Oncogene 26: 4590–4595.

27. DimriM, BommiPV, SahasrabuddheAA, KhandekarJD, DimriGP (2010) Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells. Carcinogenesis 31: 489–495.

28. RizzoS, HerseyJM, MellorP, DaiW, Santos-SilvaA, et al. (2011) Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2. Mol Cancer Ther 10: 325–335 doi:10.1158/1535-7163.MCT-10-0788.

29. SuvàM-L, RiggiN, JaniszewskaM, RadovanovicI, ProveroP, et al. (2009) EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res 69: 9211–9218 doi:10.1158/0008-5472.CAN-09-1622.

30. UgolkovAV, EisengartLJ, LuanC, YangXJ (2011) Expression analysis of putative stem cell markers in human benign and malignant prostate. Prostate 71: 18–25 doi:10.1002/pros.21217.

31. BabbioF, PistoreC, CurtiL, CastiglioniI, KunderfrancoP, et al. (2012) The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression. Oncogene Available: http://www.ncbi.nlm.nih.gov/pubmed/22330138. Accessed 17 July 2012.

32. FujimotoN, KitamuraS, KannoJ (2011) Androgen dependent transcription of a mouse prostatic protein gene, PSP94: involvement of estrogen receptors. J Steroid Biochem Mol Biol 127: 301–306 doi:10.1016/j.jsbmb.2011.08.001.

33. HeWW, SciavolinoPJ, WingJ, AugustusM, HudsonP, et al. (1997) A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics 43: 69–77 doi:S0888-7543(97)94715-7[pii]10.1006/geno.1997.4715.

34. ThomasMA, PreeceDM, BentelJM (2010) Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3′ untranslated region. Biochem J 425: 575–583 doi:10.1042/BJ20091109.

35. PomerantzMM, ShresthaY, FlavinRJ, ReganMM, PenneyKL, et al. (2010) Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis. PLoS Genet 6: e1001204 doi:10.1371/journal.pgen.1001204.

36. GardeSV, BasrurVS, LiL, FinkelmanMA, KrishanA, et al. (1999) Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis. Prostate 38: 118–125.

37. ReevesJR, DuludeH, PanchalC, DaigneaultL, RamnaniDM (2006) Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy. Clin Cancer Res 12: 6018–6022 doi:10.1158/1078-0432.CCR-06-0625.

38. TrasinoSE, KimYS, WangTT (2009) Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells. Mol Cancer Ther Available: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19531574.

39. MouzatK, MercierE, PolgeA, EvrardA, BaronS, et al. (2011) A common polymorphism in NR1H2 (LXRbeta) is associated with preeclampsia. BMC Med Genet 12: 145 doi:10.1186/1471-2350-12-145.

40. LeiQ, JiaoJ, XinL, ChangC-J, WangS, et al. (2006) NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss. Cancer Cell 9: 367–378 doi:10.1016/j.ccr.2006.03.031.

41. PeetDJ, TurleySD, MaW, JanowskiBA, LobaccaroJM, et al. (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93: 693–704.

42. RepaJJ, TurleySD, LobaccaroJA, MedinaJ, LiL, et al. (2000) Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289: 1524–1529.

43. RepaJJ, LundEG, HortonJD, LeitersdorfE, RussellDW, et al. (2000) Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding. J Biol Chem 275: 39685–39692.

44. VolleDH, MouzatK, DuggavathiR, SiddeekB, DechelotteP, et al. (2007) Multiple roles of the nuclear receptors for oxysterols liver X receptor to maintain male fertility. Mol Endocrinol 21: 1014–1027.

45. BernsteinBE, MikkelsenTS, XieX, KamalM, HuebertDJ, et al. (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315–326.